Re-examining the Plaque-Gingivitis Connection and the Role of Stannous Fluoride
COURSE NUMBER: 579
Sherri M. Lukes, RDH, MS, FAADH; Shelly L. Campbell, RDH, MPH
Credit Hours:
2 Hour(s)
SHARE
The purpose of this course is to review the role of plaque in the initiation of periodontal disease, share novel insights on the mechanism by which stannous fluoride reduces plaque-induced gingivitis, and discuss practical implications for ...
(Use this feature to create assignments for your students and staff.)
Overview
The purpose of this course is to review the role of plaque in the initiation of periodontal disease, share novel insights on the mechanism by which stannous fluoride reduces plaque-induced gingivitis, and discuss practical implications for dental professionals.
Intended Audience:
Dentists, Dental Hygienists, Dental Assistants, Dental Students, Dental Hygiene Students, Dental Assisting Students
Date Course Online:
Mar 1, 2019
Last Revision Date:
Mar 15, 2024
Course Expiration Date:
Mar 14, 2027
Cost:
Free
Method:
Self-instructional
AGD Subject Code(s):
490
Learning Objectives
Upon the completion of this course, the dental professional should be able to:
- Explain the risk factors associated with gingivitis, including the contribution of plaque quantity and host susceptibility.
- Identify common chemotherapeutic oral antimicrobials and their respective benefits, and describe how stannous fluoride is distinct in its modes of action in gingivitis reduction.
- Define the mechanism by which stannous fluoride interacts with plaque bacterial endotoxins to reduce the inflammatory response.
- Discuss the implications of bioavailable stannous fluoride use for patient care.
Disclaimers
- P&G is providing these resource materials to dental professionals. We do not own this content nor are we responsible for any material herein.
- Participants must always be aware of the hazards of using limited knowledge in integrating new techniques or procedures into their practice. Only sound evidence-based dentistry should be used in patient therapy.
Note: Registration is required to take test.
Author(s)
Conflict of Interest Disclosure Statement
- The authors have done consulting work for Procter & Gamble. They have no relevant financial relationships to disclose.
Sherri M. Lukes
RDH, MS, FAADH
Shelly L. Campbell
RDH, MPH
Submission Information
Academy of General Dentistry (AGD) Submission For credit transfers to appear in your AGD account in real time, make sure to add your AGD membership number in the field provided on the “Share Your Test Score” page.
CE Broker For all states that use CE Broker for licensure, “proof of completions” are electronically reported the first of every month. If a course was taken in November, the “proof of completion” will be submitted the beginning of December.
Recognition
Approved PACE Program Provider
THE PROCTER & GAMBLE COMPANY
Nationally Approved PACE Program Provider for FAGD/MAGD credit.
Approval does not imply acceptance by any regulatory authority or AGD endorsement.
8/1/2021 to 7/31/2027
Provider ID# 211886
(Use this feature to create assignments for your students and staff.)